TrialBreast cancer research and treatment2018

21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: results from NSABP B-28/NRG Oncology.

Eleftherios P Mamounas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.